Who is sponsoring NCT03990311?

NCT03990311 is sponsored by Tufts Medical Center.

What drugs are being tested in NCT03990311?

Interventions in NCT03990311: Sodium Restricted Meals, Control.

What condition does NCT03990311 study?

NCT03990311 studies Hypertension in Dialysis Patients, Fluid Overload in Dialysis Patients.

Is NCT03990311 still recruiting?

NCT03990311 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT03990311: PEPPERDISH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis

Completed NA Last updated 18 January 2023

What this trial tests

NA trial testing Sodium Restricted Meals in Hypertension in Dialysis Patients in 40 participants. Completed in 31 December 2021.

Timeline

5 June 2019

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Tufts Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	5 June 2019
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across United States

Drugs / interventions tested

Sodium Restricted Meals
Control

Conditions studied

Hypertension in Dialysis Patients — all drugs for Hypertension in Dialysis Patients →
Fluid Overload in Dialysis Patients — all drugs for Fluid Overload in Dialysis Patients →

Sponsor

Tufts Medical Center

Who can join

18 and older, any sex, with Hypertension in Dialysis Patients or Fluid Overload in Dialysis Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized clinical trial in which maintenance hemodialysis patients will be provided with salt restricted 'dialysis friendly' meals and compared to a control arm receiving usual care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tufts Medical Center trials

Trials by the same sponsor.

NCT07386041 — Lung Ultrasound-Guided Respiratory Management in Infants · NA · not yet recruiting
NCT06016517 — Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis · not yet recruiting
NCT07473713 — Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia · Phase 1 · recruiting
NCT07097168 — Using WHOOP Fitness Band to Measure Heart Health Variability Before and After Surgery · withdrawn
NCT06384898 — Remote Tai Chi for Knee Osteoarthritis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03990311 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tufts Medical Center
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03990311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing